Canaccord Lowers Else Nutrition Estimates After Disappointing Quarter

This past week, Else Nutrition (CSE: BABY) reported their second quarter financial results. The company reported revenues of $1.11 million, down roughly 2% sequentially, while gross profit grew from $0.05 million to $0.33 million. Finally, the company posted a net loss of $4.75 million or a loss of $0.05 per share. The company ended the quarter with $17.9 million in cash and equivalents.

The company currently only has one analyst covering the stock, Canaccord Genuity, who has a C$5.75 price target and speculative buy rating. They call the earnings a mixed bag while Else missed all of Canaccord’s estimates by 15-30%. Canaccord estimated that second-quarter revenues would come in at $1.61 million while gross profit was expected to be $0.483 million. Adjusted EBITA came in at ($3,188) million while Canaccord estimated ($3,891) million.

Canaccord says that this quarter’s revenue miss was due to retail order lumpiness. The miss was attributed to weaker-than-expected toddler formula sales of $0.8 million versus their $1.3 million estimate. They say that the online sales have been solid with Amazon store sales up 50% and their own website sales up 34%. They write, “the online channel has been strong and steady, retail sales have been lumpy as they depend on the timing of orders received from distributors.”

Canaccord went ahead and lowered their full-year 2021 and 2022 estimate due to lowering their toddler formula revenue going forward. They also mention that the baby complementary cereal is still on track to launch during the fourth quarter of this year on time and is in line with their projections.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

One Response

Video Articles

Why $50 Silver, $4000 Gold Might Be Closer Than Anyone Thinks | Bradley Langille – GoGold Resources

Why Silver’s True Price Could Be Much Higher | Joaquín Marias – Argenta Silver

Gold Enters A ‘Stronger For Longer’ Phase | Richard Young – i-80 Gold

Recommended

Emerita Reports Aznalcollar Public Tender Trial Hearings Have Concluded, Verdict Expected This Fall

Antimony Resources Completes 16 Hole Drill Program At Bald Hill Antimony Project, Assays Pending

Related News

Market Movers: Else Nutrition

Plant-based baby formula startup Else Nutrition Holdings Inc. (TSXV: BABY) has been a fixture of...

Saturday, June 20, 2020, 10:30:00 AM

Lundin Gold Sees $14 Price Target Reiterated By BMO

Lundin Gold Inc. (TSX: LUG) last week announced it’s third-quarter production results. The company said...

Monday, October 10, 2022, 03:15:00 PM

WeCommerce: TD, Canaccord Raise Price Targets After Leading Bought Deal

Last week, WeCommerce (TSXV: WE) announced that their bought deal closed. The company issued 2.81...

Friday, July 16, 2021, 04:09:00 PM

Netflix: BMO Reiterates $700 Price Target After Q3 Results

Last week, Netflix (NASDAQ: NFLX) reported their fiscal third quarter financial results. The company reported...

Friday, October 29, 2021, 04:51:00 PM

BofA Terminates Coverage On Tilray, Aurora Cannabis

On November 18th, Bank of America terminated coverage on Tilray Inc (TSX: TLRY) and Aurora...

Friday, November 19, 2021, 11:47:00 AM